Most defense lawyers, if given the choice, would probably pick North Carolina and Montana over New Jersey and Rhode Island as places to try cases.  But as we mentioned yesterday, the bisphosphonate litigation continues chugging along in its merry, contrarian way.

In the federal litigation that’s being thrown off by the Aredia/Zometa MDL, the